Клинические рекомендации 2023 / Методические рекомендации по применению смесей (част гидр)
.pdf51.Vandenplas Y, Latiff AHA, Fleischer DM, Gutiérrez-Castrellón P, Miqdady MIS, Smith PK, et al. Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensus. Nutrition [Internet]. 2019 Jan 1 [cited 2022 Jul 29];57:268–74. Available from: https://pubmed.ncbi.nlm.nih.gov/30223233/
52.Vandenplas Y, Latiff AHA, Fleischer DM, Gutiérrez-Castrellón P, Miqdady MIS,
Smith PK, et al. Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensus. Nutrition. 2019 Jan;57:268–74.
53.Vandenplas Y, Latiff AHA, Fleischer DM, Gutiérrez-Castrellón P, Miqdady MIS,
Smith PK, et al. Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensus. Nutrition [Internet]. 2019 Jan 1 [cited 2022 Nov 28];57:268–74. Available from: https://pubmed.ncbi.nlm.nih.gov/30223233/
54.Picaud JC, Pajek B, Arciszewska M, Tarczón I, Escribano J, Porcel R, et al. An
Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial. Nutrients [Internet]. 2020 Jul 1 [cited 2022 Nov 28];12(7):1–16. Available from: /pmc/articles/PMC7400250/
55.Berg A, Filipiak Pittroff B, Schulz H, Hoffmann U, Link E, Sußmann M, et al.
Allergic manifestation 15 years after early intervention with hydrolyzed formulas
– the <scp>GINI</scp> Study. Allergy. 2016 Feb 23;71(2):210–9.
56.Berg A von, Filipiak-Pittroff B, Krämer U, Link E, Heinrich J, Koletzko S, et al.
The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergol Select. 2017 Jan 1;1(1):28–39.
57.Osborn DA, Sinn JK, Jones LJ. Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. In: Sinn JK, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2017.
58.McGuire W, Soll R. Commentary on “Infant Formulas Containing Hydrolysed Protein for Prevention of Allergic Disease and Food Allergy.” Neonatology
[Internet]. 2019 Oct 1 [cited 2022 Aug 16];116(3):286–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31121598/
59.Castenmiller J, Hirsch-Ernst KI, Kearney J, Knutsen HK, Maciuk A, Mangelsdorf I, et al. Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by
Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis. EFSA Journal. 2021 Jun 1;19(6).
61
60.Fleischer DM, Spergel JM, Assa’ad AH, Pongracic JA. Primary Prevention of
Allergic Disease Through Nutritional Interventions. J Allergy Clin Immunol Pract. 2013 Jan;1(1):29–36.
61.Muraro A, Halken S, Arshad SH, Beyer K, Dubois AEJ, du Toit G, et al. EAACI Food Allergy and Anaphylaxis Guidelines. Primary prevention of food allergy. Allergy. 2014 May;69(5):590–601.
62.Recto MST, Genuino MLG, Castor MAR, Casis-Hao RJ, Tamondong-Lachica DR, Sales MI v., et al. Dietary primary prevention of allergic diseases in children: the Philippine guidelines. Asia Pac Allergy. 2017;7(2):102.
63.de Silva D, Halken S, Singh C, Muraro A, Angier E, Arasi S, et al. Preventing food allergy in infancy and childhood: Systematic review of randomised controlled trials. Pediatr Allergy Immunol [Internet]. 2020 Oct 1 [cited 2022 Aug 16];31(7):813–26. Available from: https://pubmed.ncbi.nlm.nih.gov/32396244/
64.Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, et al. EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update). Pediatric Allergy and Immunology. 2021 Jul 1;32(5):843– 58.
65.Vandenplas Y, Al-Hussaini B, Al-Mannaei K, Al-Sunaid A, Ayesh WH, El-
Degeir M, et al. Prevention of Allergic Sensitization and Treatment of Cow’s Milk
Protein Allergy in Early Life: The Middle-East Step-Down Consensus. Nutrients [Internet]. 2019 Jul 1 [cited 2022 Aug 16];11(7). Available from: /pmc/articles/PMC6683055/
66.Koletzko S, Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S, et al.
Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr [Internet]. 2012 Aug [cited 2022 Aug 16];55(2):221–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22569527/
67.Taniuchi S, Takahashi M, Soejima K, Hatano Y, Minami H. Immunotherapy for cow’s milk allergy. Hum Vaccin Immunother [Internet]. 2017 Oct 3 [cited 2022 Oct 14];13(10):2443. Available from: /pmc/articles/PMC5647979/
68.Ogata M, Kido J, Nakamura K. Oral Immunotherapy for Children with Cow’s
Milk Allergy. Pathogens [Internet]. 2021 Oct 1 [cited 2022 Oct 14];10(10). Available from: /pmc/articles/PMC8539286/
69.Субботина ОА. Механизм развития и патогенетическая терапия гастроинтестинальной пищевой аллергии у детей . [Москва]; 1996.
70.Bognanni A, Chu DK, Firmino RT, Arasi S, Waffenschmidt S, Agarwal A, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against
62
Cow’s Milk Allergy (DRACMA) guideline update - XIII - Oral immunotherapy for CMA - Systematic review. World Allergy Organ J [Internet]. 2022 Sep 1 [cited 2022 Oct 30];15(9). Available from: https://pubmed.ncbi.nlm.nih.gov/36185550/
71.Inuo C, Tanaka K, Suzuki S, Nakajima Y, Yamawaki K, Tsuge I, et al. Oral
Immunotherapy Using Partially Hydrolyzed Formula for Cow’s Milk Protein
Allergy: A Randomized, Controlled Trial. Int Arch Allergy Immunol [Internet]. 2018 Oct 1 [cited 2022 Oct 14];177(3):259. Available from: /pmc/articles/PMC6262684/
72.Бельмер СВ, Волынец ГВ, Горелов АВ, Гурова MM, Звягин AA, Корниенко EA, et al. Функциональные расстройства органов пищеварения у детей. Рекомендации Общества детских гастроэнтерологов, гепатологов и нутрициологов. Часть 1. РОССИЙСКИЙ ВЕСТНИК ПЕРИНАТОЛОГИИ И ПЕДИАТРИИ. 2020 Sep 25;65(4):150–61.
73.Vandenplas Y, Salvatore S. Infant Formula with Partially Hydrolyzed Proteins in Functional Gastrointestinal Disorders. In 2016. p. 29–37.
74.Savino F, Maccario S, Castagno E, Cresi F, Cavallo F, Dalmasso P, et al. Advances in the management of digestive problems during the first months of life. Acta Paediatr. 2007 Jan 2;94:120–4.
75.Savino F, Palumeri E, Castagno E, Cresi F, Dalmasso P, Cavallo F, et al. Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr. 2006 Nov 1;60(11):1304–10.
76.Bongers ME, de Lorijn F, Reitsma JB, Groeneweg M, Taminiau JA, Benninga MA. The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial. Nutr J. 2007 Dec 11;6(1):8.
77.Vandenplas Y, Alarcon P, Fleischer D, Hernell O, Kolacek S, Laignelet H, et al. Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):22–35.
78.Клинические рекомендации. ФУНКЦИОНАЛЬНЫЕ РАССТРОЙСТВА ОРГАНОВ ПИЩЕВАРЕНИЯ У ДЕТЕЙ. 2020.
79.Мигачёва Н.Б., Мухаметова Е.М., Макарова Е.Г., Украинцев С.Е. РОЛЬ И МЕСТО СМЕСЕЙ НА ОСНОВЕ ЧАСТИЧНО ГИДРОЛИЗОВАННЫХ БЕЛКОВ В ПИТАНИИ ДОНОШЕННЫХ ДЕТЕЙ: ПИЩЕВАРИТЕЛЬНЫЙ КОМФОРТ И ПРЕДУПРЕЖДЕНИЕ АЛЛЕРГИИ. Вопросы современной педиатрии [Internet]. 2020 [cited 2022 Jul 8];4. Available from: https://cyberleninka.ru/article/n/rol-i-mesto-smesey-na-osnove-chastichno-
63
gidrolizovannyh-belkov-v-pitanii-donoshennyh-detey-pischevaritelnyy-komfort- i/viewer
80.Vandenplas Y, Leluyer B, Cazaubiel M, Housez B, Bocquet A. Double-blind comparative trial with 2 antiregurgitation formulae. J Pediatr Gastroenterol Nutr [Internet]. 2013 Sep [cited 2022 Jul 8];57(3):389–93. Available from: https://pubmed.ncbi.nlm.nih.gov/23648788/
81.Захарова И.Н., Сугян Н.Г., Андрюхина Е.Н., Дмитриева Ю.А. Тактика педиатра при младенческих кишечных коликах. Русский медицинский журнал. 2010;1:11.
82.Campbell JP. Dietary treatment of infant colic: a double-blind study. J R Coll Gen Pract [Internet]. 1989 Jan [cited 2022 Jul 26];39(318):11. Available from: /pmc/articles/PMC1711543/?report=abstract
83.Lucassen PLBJ, Assendelft WJJ, Gubbels JW, van Eijk JTM, van Geldrop WJ, Knuistingh Neven A. Effectiveness of treatments for infantile colic: systematic review. BMJ : British Medical Journal [Internet]. 1998 May 5 [cited 2022 Jul
26];316(7144):1563. Available from: /pmc/articles/PMC28556/
84.Oggero R, Garbo G, Savino F, Mostert M. Dietary modifications versus dicyclomine hydrochloride in the treatment of severe infantile colics. Acta Paediatr [Internet]. 1994 [cited 2022 Jul 26];83(2):222–5. Available from: https://pubmed.ncbi.nlm.nih.gov/8193507/
85.Красавина Н.А., Кабанова Н.К., Перминова О.А., Дембовская Л.В., Мусихина А.Ю., Славнова Н.П., et al. Возможности диетологической коррекции сочетанных форм функциональных расстройств пищеварения у детей первого года жизни: результаты клинической апробации нового продукта в открытом сравнительном проспективном исследовании. Вопросы детской диетологии. 2017;15(6):18–24.
86.Gutiérrez-Castrellón P, Indrio F, Bolio-Galvis A, Jiménez-Gutiérrez C, JimenezEscobar I, López-Velázquez G. Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis. Medicine [Internet]. 2017 Dec 1 [cited 2022 Jul 8];96(51). Available from: https://pubmed.ncbi.nlm.nih.gov/29390535/
87.Tabbers MM, Dilorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations From ESPGHAN and NASPGHAN. 2014 [cited 2022 Jul 8]; Available from: http://www.cebm.net
88.Czerkies LA, Kineman BD, Cohen SS, Reichert H, Carvalho RS. A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially
64
Hydrolyzed Whey or Intact Protein-Based Infant Formulas. Int J Pediatr [Internet]. 2018 Nov 1 [cited 2022 Jul 8];2018:1–7. Available from: https://pubmed.ncbi.nlm.nih.gov/30515226/
89.Zani A, Eaton S, Puri P, Rintala R, Lukac M, Bagolan P, et al. International survey on the management of necrotizing enterocolitis. Eur J Pediatr Surg [Internet]. 2015 [cited 2022 Oct 7];25(1):27–33. Available from: https://pubmed.ncbi.nlm.nih.gov/25344942/
90.Cordova J, Sriram S, Patton T, Jericho H, Gokhale R, Weinstein D, et al. Manifestations of Cow’s-Milk Protein Intolerance in Preterm Infants. J Pediatr Gastroenterol Nutr [Internet]. 2016 [cited 2022 Oct 7];62(1):140–4. Available from: https://pubmed.ncbi.nlm.nih.gov/26252918/
91.Beck C, Koplin J, Dharmage S, Wake M, Gurrin L, McWilliam V, et al. Persistent Food Allergy and Food Allergy Coexistent with Eczema Is Associated with Reduced Growth in the First 4 Years of Life. J Allergy Clin Immunol Pract [Internet]. 2016 Mar 1 [cited 2022 Oct 7];4(2):248-256.e3. Available from: https://pubmed.ncbi.nlm.nih.gov/26441150/
92.Dangin M, Boirie Y, Garcia-Rodenas C, Gachon P, Fauquant J, Callier P, et al. The digestion rate of protein is an independent regulating factor of postprandial protein retention. American Journal of Physiology-Endocrinology and Metabolism. 2001 Feb 1;280(2):E340–8.
93.Tessari P, Kiwanuka E, Cristini M, Zaramella M, Enslen M, Zurlo C, et al. Slowversus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes. Diabetes Metab Res Rev. 2007 Jul;23(5):378–85.
94.Schaafsma G. Safety of protein hydrolysates, fractions thereof and bioactive peptides in human nutrition. Eur J Clin Nutr. 2009 Oct 22;63(10):1161–8.
95.Hummel S, Beyerlein A, Tamura R, Uusitalo U, Andrén Aronsson C, Yang J, et al. First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Diabetes Care. 2017 Mar 1;40(3):398–404.
96.Knip M, Åkerblom HK, al Taji E, Becker D, Bruining J, Castano L, et al. Effect of
Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes. JAMA. 2018 Jan 2;319(1):38.
97.Shahkhalili Y, Monnard C, Grathwohl D, Sauser J, Beaumont M, Zufferey CA, et al. Comparison of the acute metabolic effect of different infant formulas and human milk in healthy adults: a randomized trial. Nutr Diabetes [Internet]. 2021
65
Jun 1 [cited 2022 Jul 11];11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33859173/
98.Hummel S, Beyerlein A, Tamura R, Uusitalo U, Andŕen Aronsson C, Yang J, et al. First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Diabetes Care [Internet]. 2017 Mar 1 [cited 2022 Jul 11];40(3):398–404. Available from: https://pubmed.ncbi.nlm.nih.gov/28096222/
99.Клинические рекомендации. ЭНТЕРАЛЬНОЕ ВСКАРМЛИВАНИЕ НЕДОНОШЕННЫХ ДЕТЕЙ. 2015.
100.Ng DHC, Klassen JRL, Embleton ND, McGuire W. Protein hydrolysate versus standard formula for preterm infants. Cochrane Database Syst Rev [Internet]. 2019 Jul 24 [cited 2022 Jul 29];7(7). Available from: https://pubmed.ncbi.nlm.nih.gov/31339557/
101.Florendo KN, Bellflower B, van Zwol A, Cooke RJ. Growth in preterm infants fed either a partially hydrolyzed whey or an intact casein/whey preterm infant formula. J Perinatol [Internet]. 2009 [cited 2022 Jul 11];29(2):106–11. Available from: https://pubmed.ncbi.nlm.nih.gov/18716627/
102.Andorsky et al., J Pediatr, 2001; 139:1; 27-33
103.Bines J, Francis D and Hill DJ. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. JPGN 1998;26:123-128
104.А.В. Харькин, Г.В. Лобачева, И.Н. Быкова. Энтеральное питание новорожденных и грудных детей в раннем послеоперационном периоде в кардиохирургии. ВДД, 2005, т.3, №2, с. 5-8.
66